Company: CMND
Filing Date: 2025-01-22
Form Type: 20-F
Source: 0001213900-25-005490
Chunk: 217

Company: Clearmind Medicine Inc.
Filing Date: 2025-01-22
Form: 20-F
Item: Item 10
Chunk 217
---
 limitations
on the assessment and collection of U. S. federal income taxes of such U. S. Holder for the related taxable year may not close until three
years after the date on which the required information is filed. U. S. Holders should consult their tax advisors regarding the effect,
if any, of these rules on the ownership and disposition of the Common Shares.

Information Reporting and Backup Withholding

Information reporting requirements may apply to
cash received in redemption of the Common Shares, dividends paid on the Common Shares and the proceeds received on the disposition of
the Common Shares effected within the United States (and, in certain cases, outside the United States), in each case other than with
respect to U. S. Holders that are exempt recipients (such as corporations). Backup withholding may apply to such amounts if the U. S. Holder
fails to provide an accurate taxpayer identification number (generally on an IRS Form W-9 provided to the paying agent of the U. S. Holder’s
broker) or is otherwise subject to backup withholding. U. S. Holders should consult their tax advisors regarding the application of the
U. S. information reporting and backup withholding rules.

F. Dividends and Paying Agents

Not applicable.

G. Statement by Experts

Not applicable.

H. Documents on Display

We are subject to certain information reporting
requirements of the Exchange Act, applicable to foreign private issuers and under those requirements will file reports with the SEC. The
SEC maintains an internet site at http://www. sec. gov that contains reports, proxy and information statements and other information regarding
issuers that file electronically with the SEC. Our filings with the SEC will also be available to the public through the SEC’s
website at www. sec. gov.

As a foreign private issuer, we are exempt from
the rules under the Exchange Act related to the furnishing and content of proxy statements, and our officers, directors and principal
shareholders will be exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act.
In addition, we are not required under the Exchange Act to file annual, quarterly and current reports and financial statements with the
SEC as frequently or as promptly as U. S. domestic companies whose securities are registered under the Exchange Act. However, we will
file with the SEC, within 120 days after the end of each fiscal year, or such applicable time as required by the SEC, an annual report
on Form 20